ELI LILLY & Co — Director's Dealing 2018

Apr 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-04-13

Reporting Person: Mahony Susan (SVP & Pres., Lilly Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-13	Common Stock	S	5165	$80.14	Disposed	45652	Direct
2018-04-16	Common Stock	S	17379	$80.08	Disposed	28273	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1738	Indirect
Common Stock	1727	Indirect
Common Stock	14874	Indirect

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 22, 2018.

F2: This transaction was executed in multiple trades at prices ranging from $80.00 to $80.41. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $80.00 to $80.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: Reporting person disclaims beneficial ownership of these shares.